David H. Coy
#92,769
Most Influential Person Now
David H. Coy's AcademicInfluence.com Rankings
David H. Coybiology Degrees
Biology
#4299
World Rank
#6428
Historical Rank
Endocrinology
#26
World Rank
#30
Historical Rank
Molecular Biology
#326
World Rank
#331
Historical Rank
Neuroscience
#447
World Rank
#466
Historical Rank

Download Badge
Biology
Why Is David H. Coy Influential?
(Suggest an Edit or Addition)David H. Coy's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. (1989) (1841)
- Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. (1991) (622)
- Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. (1974) (555)
- The antimicrobial peptides and their potential clinical applications. (2019) (494)
- Dynorphin immunocytochemistry in the rat central nervous system (1982) (311)
- Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. (1997) (306)
- Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. (1993) (278)
- CNS effects of peripherally administered brain peptides. (1979) (275)
- Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. (1973) (271)
- Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. (1974) (247)
- Nonopiate effects of dynorphin and des-Tyr-dynorphin. (1982) (231)
- Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas (2008) (224)
- Corticotropin-releasing factor stimulates accumulation of adenosine 3', 5'-monophosphate in rat pituitary corticotrophs. (1982) (184)
- NEW HYPOTHALAMIC HORMONE, CORTICOTROPIN-RELEASING FACTOR, SPECIFICALLY STIMULATES THE RELEASE OF ADRENOCORTICOTROPIC HORMONE AND CORTISOL IN MAN (1982) (184)
- Probing peptide backbone function in bombesin. A reduced peptide bond analogue with potent and specific receptor antagonist activity. (1988) (183)
- Inhibition of testicular luteinizing hormone receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist of human chorionic gonadotropin. (1977) (177)
- Progress in the development of potent bombesin receptor antagonists. (1991) (170)
- DIRECT INHIBITION OF GASTRIC ACID AND PEPSIN SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONE IN CATS (1975) (163)
- Reduction of distress vocalization in chicks by opiate-like peptides (1978) (159)
- Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. (1985) (157)
- Stimulation of cyclic AMP accumulation and corticotropin release by synthetic ovine corticotropin-releasing factor in rat anterior pituitary cells: site of glucocorticoid action. (1982) (155)
- Discovery of a High Affinity Radioligand for the Human Orphan Receptor, Bombesin Receptor Subtype 3, Which Demonstrates That It Has a Unique Pharmacology Compared with Other Mammalian Bombesin Receptors* (1997) (155)
- Radioimmunoassay of somatostatin. (1978) (155)
- An analog of enkephalin having prolonged opiate-like effects in vivo. (1977) (154)
- [Psi13,14] Bombesin Analogues Inhibit Growth of Small Cell Lung Cancer in Vitro and in Vivo (1991) (150)
- CORTICOTROPHIN RELEASING FACTOR: RESPONSES IN NORMAL SUBJECTS AND PATIENTS WITH DISORDERS OF THE HYPOTHALAMUS AND PITUITARY (1984) (148)
- Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain (1997) (147)
- Potent inhibitory activity of [D-Leu6, Des-Gly-NH2(10)]LHRH ethylamide on LH/hCG and PRL testicular receptor levels in the rat. (1977) (146)
- Growth Hormone Release Inhibiting Hormone in Acromegaly (1974) (145)
- Stimulation of prolactin release in the rat by intraventricular injection of beta-endorphin and methionine-enkephalin. (1977) (141)
- Inhibition of adenosine 3',5'-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormone. (1974) (140)
- Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin. (1976) (137)
- Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion. (1976) (133)
- Studies on the interaction of endorphins, substance P. and endogenous somatostatin in growth hormone and prolactin release in rats. (1978) (132)
- Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. (1997) (131)
- Solid phase synthesis of peptides containing the CH2NH peptide bond isostere (1987) (129)
- In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue. (1988) (126)
- Somatostatin Receptor-mediated Signaling in Smooth Muscle (1996) (126)
- Synthesis and opioid activities of stereoisomers and other D-amino acid analogs of methionine-enkephalin. (1976) (125)
- Glucagon control of fasting glucose in man. (1974) (123)
- Enkephalin and a potent analog facilitate maze performance after intraperitoneal administration in rats (1976) (123)
- Renal responses to intra-arterial administration of adrenomedullin in dogs. (1996) (122)
- Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4‐2J (1990) (121)
- MIF-I's differential actions as an opiate antagonist (1979) (120)
- The somatostatin receptor subtype on rat enterochromaffinlike cells. (1994) (119)
- Calcium-sensing receptor is a physiologic multimodal chemosensor regulating gastric G-cell growth and gastrin secretion (2010) (119)
- Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats. (2003) (118)
- The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK (1990) (117)
- An in Vivo Model for Elucidation of the Mechanism of Tumor Necrosis Factor-α (TNF-α)-Induced Insulin Resistance: Evidence for Differential Regulation of Insulin Signaling by TNF-α. (1998) (117)
- Edward T. Tyler Prize Oration: LH-releasing hormone and its analogues: recent basic and clinical investigations. (1976) (115)
- Super-active analogs of growth hormone-releasing factor (1-29)-amide. (1984) (113)
- Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat (1982) (113)
- Analogs of luteinizing hormone-releasing hormone with increased biological activity produced by D-amino acid substitutions in position 6. (1976) (111)
- Corticotropin-releasing factor stimulates secretion of melanocyte-stimulating hormone from the rat pituitary. (1982) (110)
- Carrier-mediated transport of enkephalins and N-Tyr-MIF-1 across blood-brain barrier. (1986) (105)
- The half-life, metabolism and excretion of tritiated luteinizing hormone-releasing hormone (LH-RH) in man. (1973) (104)
- Somatostatin receptor-targeted anti-cancer therapy. (2011) (103)
- Distribution of 3H-α-MSH in rat brain (1976) (102)
- Adrenomedullin: a hypotensive hormone in man. (1997) (100)
- Neuropharmacological actions of enkephalin after systemic administration. (1976) (100)
- des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists. (1990) (98)
- Enkephalin and other peptides reduce passiveness (1978) (97)
- Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes. (1998) (97)
- Specific inhibition of rat pancreatic insulin or glucagon release by receptor-selective somatostatin analogs. (1994) (96)
- Proceedings: Effect of somatostatin on motilin levels and gastric emptying. (1975) (96)
- Potent bombesin receptor antagonists distinguish receptor subtypes. (1990) (94)
- Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists. (2002) (92)
- Blood-brain barrier, half-time disappearance, and brain distribution for labeled enkephalin and a potent analog (1976) (92)
- Synthesis and biological properties of (D-Ala-6, des-Gly-NH2-10)-LH-RH ethylamide, a peptide with greatly enhanced LH- and FSH- releasing activity. (1974) (90)
- GROWTH-HORMONE-RELEASING FACTOR IN GROWTH HORMONE DEFICIENCY: DEMONSTRATION OF A HYPOTHALAMIC DEFECT IN GROWTH HORMONE RELEASE (1983) (90)
- Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity. (1989) (89)
- Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells. (1990) (86)
- Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies. (1997) (85)
- Comparison of methionine-enkephalin and morphine in the stimulation of gastric acid secretion in the dog. (1980) (84)
- Additional evidence that small amounts of a peptide can cross the blood-brain barrier (1979) (83)
- Recent approaches to fertility control based on derivative of LH-RH. (1980) (81)
- An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha. (1998) (81)
- Insights into bombesin receptors and ligands: Highlighting recent advances (2015) (80)
- Solid phase synthesis of growth hormone-release inhibiting factor. (1973) (79)
- Synthesis and biological actions of prosomatostatin. (1980) (79)
- Synthesis and biological properties of (Leu-6)-LH-RH and (D-Leu-6,desGly-NH210)-LH-RH ethylamide. (1974) (77)
- LH‐RH Agonists and Antagonists (1980) (77)
- Hemodynamic, hormonal, and renal effects of adrenomedullin in conscious sheep. (1997) (77)
- Development of High Affinity Camptothecin-Bombesin Conjugates That Have Targeted Cytotoxicity for Bombesin Receptor-containing Tumor Cells* (2004) (74)
- A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line. (1988) (73)
- Solid-phase synthesis and biological properties of psi [CH2NH] pseudopeptide analogues of a highly potent somatostatin octapeptide. (1987) (72)
- Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo. (1997) (71)
- Ability of Various Bombesin Receptor Agonists and Antagonists to Alter Intracellular Signaling of the Human Orphan Receptor BRS-3* (1998) (70)
- Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes. (1985) (70)
- Pituitary adenylate cyclase activating peptide receptors regulate the growth of non-small cell lung cancer cells. (1995) (70)
- Different receptors mediate the action of bombesin-related peptides on gastric smooth muscle cells. (1991) (69)
- Characterization of binding sites for N-Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in rat brain (1982) (69)
- Structure-activity studies on the N-terminal region of growth hormone releasing factor. (1985) (69)
- A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis. (1995) (68)
- Galanin binding sites in rat gastric and jejunal smooth muscle membrane preparations (1990) (68)
- Highly potent cyclic disulfide antagonists of somatostatin. (1999) (68)
- Long-term Infusion of Growth Hormone Release Inhibiting Hormone in Acromegaly: Effects on Pituitary and Pancreatic Hormones (1974) (67)
- Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5. (1999) (67)
- Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors. (1992) (66)
- Reversal of Somatostatin Inhibition of Insulin and Glucagon Secretion (1976) (66)
- Interaction of Bombesin and Related Peptides with Receptors on Pancreatic Acinar Cells (1988) (66)
- Adrenomedullin, amylin, calcitonin gene-related peptide and their fragments are potent inhibitors of gastric acid secretion in rats. (1997) (65)
- THE CORTISOL RESPONSE TO CORTICOTROPHIN‐RELEASING FACTOR IS BLUNTED IN OBESITY (1988) (64)
- Characterization of a putative cellular receptor for HIV-1 transmembrane glycoprotein using synthetic peptides. (1990) (64)
- Differential binding of somatostatin agonists to somatostatin receptors in brain and adenohypophysis. (1987) (64)
- Peptide antagonists of LH-RH: large increases in antiovulatory activities produced by basic D-amino acids in the six position. (1982) (63)
- Response of human lung tumor xenografts to treatment with a somatostatin analogue (Somatuline). (1990) (63)
- Rational Design of a Peptide Agonist That Interacts Selectively with the Orphan Receptor, Bombesin Receptor Subtype 3* (2001) (62)
- Cardiopulmonary pharmacology of enkephalins in the conscious dog (1981) (61)
- A chimeric VIP-PACAP analogue but not VIP pseudopeptides function as VIP receptor antagonists (1994) (61)
- Receptor-specific somatostatin analogs: correlations with biological activity. (1996) (61)
- [D-Phe12]bombesin analogues: a new class of bombesin receptor antagonists. (1987) (61)
- Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin. (1987) (61)
- Evidence that [125I]N-Tyr-delta sleep-inducing peptide crosses the blood-brain barrier by a non-competitive mechanism (1984) (61)
- Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides. (1992) (61)
- Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design. (2004) (60)
- Somatostatin Receptor Type 2 Antagonism Improves Glucagon and Corticosterone Counterregulatory Responses to Hypoglycemia in Streptozotocin-Induced Diabetic Rats (2011) (60)
- Absence of LH-RH binding sites in corpora lutea from rhesus monkeys (Macacca mulatta). (1981) (60)
- LH-releasing activity of potent LH-RH analogs in vitro. (1975) (60)
- Developmental, behavioral, and opiate receptor changes after prenatal or postnatal β-endorphin, CRF, or Tyr-MIF-1 (1985) (59)
- Somatostatin receptor subtype 2 mediates somatostatin inhibition of ion secretion in rat distal colon. (1996) (59)
- Chimeric galanin analogs that function as antagonists in the CNS are full agonists in gastrointestinal smooth muscle. (1993) (58)
- Pituitary adenylate cyclase-activating polypeptide relaxes rat gastrointestinal smooth muscle. (1992) (58)
- Receptor-binding properties of gonadotropin-releasing hormone derivatives. Prolonged receptor occupancy and cell-surface localization of a potent antagonist analog. (1984) (58)
- Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines. (1992) (58)
- Tyr-MIF-1, identified in brain tissue, and its analogs are active in two models of antinociception (1985) (57)
- Somatostatin receptor subtype 2 mediates inhibition of gastrin and histamine secretion from human, dog, and rat antrum. (1996) (56)
- Radioimmunoassay of DSIP-like material in rat brain (1978) (56)
- Characterization of somatostatin receptor subtypes controlling rat gastric acid and pancreatic amylase release (1994) (56)
- Effect of somatostatin on myoelectrical activity of small bowel. (1978) (56)
- Growth hormone release inhibiting hormone: actions on thyrotrophin and prolactin secretion after thyrotrophinreleasing hormone. (1975) (55)
- Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes. (1993) (55)
- Examination of somatostatin involvement in the inhibitory action of GIP, GLP‐1, amylin and adrenomedullin on gastric acid release using a new SRIF antagonist analogue (1998) (54)
- Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues. (1993) (54)
- Permeability of blood-brain barrier to DSIP peptides (1981) (54)
- Endorphin analogs with potent and long-lasting analgesic effects (1977) (54)
- Inhibition of growth hormone and thyrotropin release by growth hormone-release inhibiting hormone. (1974) (54)
- Peptides readily penetrate the blood-brain barrier: Uptake of peptides by synaptosomes is passive (1976) (53)
- Isolation and structure of pro-methionine-enkephalin: Potential enkephalin precursor from porcine hypothalamus. (1979) (53)
- Inhibition of pancreatic secretion by enkephalin and morphine in dogs (1978) (53)
- Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase. (2006) (53)
- Characterization of Vasoactive Intestinal Peptide (VIP) receptors in mammalian lung (1986) (52)
- Bombesin-like peptides and mast cell responses: relevance to bronchopulmonary dysplasia? (2003) (52)
- Gastrin secretion from human antral G cells in culture. (1990) (52)
- Radioimmunoassay of DSIP-like material in human blood: Possible protein binding (1981) (52)
- Cranial irradiation for cerebral and nasopharyngeal tumours in children: evidence for the production of a hypothalamic defect in growth hormone release. (1986) (52)
- Interaction of galanin fragments with galanin receptors on isolated smooth muscle cells from guinea pig stomach: identification of a novel galanin receptor subtype. (1995) (51)
- Hindbrain GRP receptor blockade antagonizes feeding suppression by peripherally administered GRP. (1996) (51)
- Solid phase reductive alkylation techniques in analogue peptide bond and sidechain modification (1988) (51)
- A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, αVβ3/αVβ5 and MMP-2/-9 (2007) (51)
- In Vitro and in Vivo Antitumor Effects of Cytotoxic Camptothecin-Bombesin Conjugates Are Mediated by Specific Interaction with Cellular Bombesin Receptors (2006) (50)
- Insulin secretion is inhibited by subtype five somatostatin receptor in the mouse. (1998) (50)
- GIP6–30amide contains the high affinity binding region of GIP and is a potent inhibitor of GIP1–42action in vitro (1997) (50)
- Stimulatory and inhibitory analogs of luteinizing hormone releasing hormone. (1974) (50)
- An extremely sensitive in vitro model for elucidating structure-activity relationships of growth hormone-releasing factor analogs. (1985) (50)
- Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonist (2001) (50)
- Endogenous opiates: 1981 (1982) (50)
- Potent inhibitory effects of a type four receptor-selective somatostatin analog on rat insulin release. (1993) (50)
- Development of a potent bombesin receptor antagonist with prolonged in vivo inhibitory activity on bombesin-stimulated amylase and protein release in the rat (1992) (49)
- Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R). (1999) (49)
- Delta sleep-inducing peptide crosses the blood-brain-barrier in dogs: Some correlations with protein binding (1982) (48)
- Interaction of vasoactive intestinal peptide (VIP) and N-terminally modified VIP analogs with rat pancreatic, hepatic and pituitary membranes. (1986) (48)
- Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells. (1998) (48)
- Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats (2013) (48)
- Corticotropin releasing factor (CRF): immunocytochemical localization and radioimmunoassay (RIA). (1982) (48)
- Highly potent and subtype selective ligands derived by N-methyl scan of a somatostatin antagonist. (2001) (48)
- Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release. (1977) (48)
- Peptone stimulates gastrin secretion from the stomach by activating bombesin/GRP and cholinergic neurons. (1992) (48)
- Comparison of the peptide structural requirements for high affinity interaction with bombesin receptors. (1995) (47)
- Increased analgesic activities of a fluorinated and a dimeric analogue of [D-Ala-2]-methionine enkephalinamide. (1978) (47)
- VIP Attenuation of the Severity of Experimental Pancreatitis Is Due to VPAC1 Receptor-Mediated Inhibition of Cytokine Production (2005) (46)
- Circular dichroism and absorption study of the structure of methionine-enkephalin in solution. (1978) (46)
- Unusual anti-reproductive properties of the analog [d-Leu6,des-Gly-NH2(10)]-luteinizing hormone-releasing hormone ethylamide in male rats. (1978) (45)
- SUPPRESSION OF GONADOTROPHIN RELEASE IN MAN BY AN INHIBITORY ANALOGUE OF L.H.-RELEASING HORMONE (1977) (45)
- Systemic administration of Met-enkephalin, (D-Ala2)-Met-enkephalin, β-endorphin, and (D-Ala2)-β-endorphin: Effects on eating, drinking and activity measures in rats (1979) (45)
- Combined Endopeptidase Inhibition and Adrenomedullin in Sheep With Experimental Heart Failure (2002) (45)
- Leucine-enkephalin: reversal of intrinsic cardiovascular stimulation by pentobarbital. (1982) (45)
- Elucidation of vasoactive intestinal peptide pharmacophore for VPAC(1) receptors in human, rat, and guinea pig. (2002) (45)
- CNS effects of somatostatin. (1978) (45)
- Peripheral administration of hypothalamic peptides results in CNS changes. (1978) (45)
- Evidence for direct production of somatostatin-14 from a larger precursor than somatostatin-28 in a phaeochromocytoma (1983) (45)
- A comparison of the clearance of ovine and human corticotrophin-releasing hormone (CRH) in man and sheep: a possible role for CRH-binding protein. (1992) (44)
- Blockade of brain bombesin/GRP receptors increases food intake in satiated rats. (1993) (44)
- Blockage of ovulation in rats by inhibitory analogs of luteinizing hormones-releasing hormone. (1976) (44)
- Activation of somatostatin receptor subtype 2 inhibits acid secretion in rats. (1995) (43)
- Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy. (1984) (43)
- Highly active position eight analogues of somatostatin and separation of peptide diastereomers by partition chromatography. (1978) (43)
- Molecular Basis for Selectivity of High Affinity Peptide Antagonists for the Gastrin-releasing Peptide Receptor* (2001) (43)
- IMPAIRMENT OF PLATELET FUNCTION BY GROWTH-HORMONE RELEASE- INHIBITING HORMONE (1975) (43)
- Neuropeptides and the blood-brain barrier in goldfish (1978) (43)
- DSIP — more than a sleep peptide? (1980) (42)
- Gastrointestinal secretory, motor, circulatory, and metabolic effects of prosomatostatin. (1981) (42)
- Possible recognition of the GnRH receptor by an antiserum against a peptide encoded by nucleotide sequence complementary to mRNA of a GnRH precursor peptide (1986) (42)
- Dissociation of the effects of amylin on osteoblast proliferation and bone resorption. (1998) (41)
- Dissociation of effects of LH-RH analogs on pituitary regulation and reproductive behavior (1980) (41)
- Differential penetration of DSIP peptides into rat brain (1982) (41)
- Endogenous opiates: Through 1978 (1979) (40)
- Tyr-MIF-1 and MIF-1 are active in the water wheel test for antidepressant drugs (1984) (40)
- Unusual Anti-Reproductive Properties of the Analog [d-Leu6,Des-Gly- N H 2 10 ]-Luteinizing Hormone-Releasing Hormone Ethylamide in Male Rats**Supported in part by National Institutes of Health Grant 5 P50 HD08338. (1978) (40)
- Hemodynamic, hormonal, and renal effects of intracerebroventricular adrenomedullin in conscious sheep. (1998) (40)
- Suppression of ovulation in the rat by an orally active antagonist of luteinizing hormone-releasing hormone. (1982) (40)
- MIF-I suppresses deprivation-induced fluid consumption in rats (1980) (40)
- Treatment of R-3327 prostate tumors with a somatostatin analogue (somatuline) as adjuvant therapy following surgical castration. (1990) (40)
- Effects of potent bombesin antagonist on exocrine pancreatic secretion in rats (1991) (40)
- PACAP (6–38) is a PACAP receptor antagonist for breast cancer cells (1999) (40)
- Notch Signaling Activation in Cervical Cancer Cells Induces Cell Growth Arrest with the Involvement of the Nuclear Receptor NR4A2 (2016) (39)
- Potent antagonists of somatostatin: synthesis and biology. (1998) (39)
- Octapeptide analogs of somatostatin exhibiting greatly enhanced in vivo and in vitro inhibition of growth hormone secretion in the rat. (1985) (39)
- EFFECTS OF PROSOMATOSTATIN ON GROWTH HORMONE AND PROLACTIN RESPONSE TO ARGININE IN MAN Comparison with Somatostatin (1981) (39)
- Antagonistic analogs of luteinizing hormone-releasing hormone are mast cell secretagogues. (1986) (39)
- Endogenous opiates: 1980 (1981) (39)
- Molecular basis of the selectivity of gastrin-releasing peptide receptor for gastrin-releasing peptide. (2002) (38)
- High affinity binding of [125I-Tyr11]somatostatin-14 to human small cell lung carcinoma (NCI-H69). (1988) (38)
- Isolation, structural elucidation and synthesis of a tetradecapeptide with in vitro ACTH-releasing activity corresponding to residues 33-46 of the alpha-chain of porcine hemoglobin. (1978) (38)
- Somatostatin and its Analogs. (2016) (38)
- Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes (1989) (38)
- Thermoregulatory and locomotor effects of DSIP: Paradoxical interaction with d-amphetamine (1980) (38)
- Organ distribution of radioactivity and disappearance of radioactivity from plasma after administration of (3H) luteinizing hormone-releasing hormone to mice and rats. (1974) (38)
- Reduced peptide bond pseudopeptide analogues of secretin. A new class of secretin receptor antagonists. (1991) (38)
- Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs (2011) (38)
- Gonadotrophin releasing hormone analogues. (1978) (37)
- Blockade of feeding inhibition by neuromedin B using a selective receptor antagonist. (1994) (37)
- PACAP(6-38) inhibits the growth of prostate cancer cells. (1998) (37)
- Neonatal administration of met-enkephalin facilitates maze performance of adult rats (1980) (37)
- Isolation and structure of several peptides from porcine hypothalami. (1980) (37)
- Prostate carcinoma tumor size in rats decreases after administration of antagonists of luteinizing hormone-releasing hormone. (1982) (37)
- Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors (2009) (37)
- Effect of substitutions in position 12 of bombesin on antagonist activity (1989) (36)
- Systemic administration of adrenomedullin(27-52) increases bone volume and strength in male mice. (2001) (36)
- Antisense peptide nucleic acids conjugated to somatostatin analogs and targeted at the n-myc oncogene display enhanced cytotoxity to human neuroblastoma IMR32 cells expressing somatostatin receptors (2002) (36)
- (D-Ala 6, Des-Gly-NH 2 10)-LH-RH-ethylamide: a new analogue with unusually high LH-RH-FSH-RH activity. (1974) (36)
- Elucidation of the Vasoactive Intestinal Peptide Pharmacophore for VPAC2 Receptors in Human and Rat and Comparison to the Pharmacophore for VPAC1 Receptors (2002) (36)
- Antagonistic actions of MIF-I on the hypothermia and hypomotility induced by beta-endorphin or morphine. (1980) (36)
- Inhibitory action of galanin on gastric acid secretion in pentobarbital-anesthetized rats. (1989) (36)
- THE INTERACTION OF GROWTH HORMONE RELEASING HORMONE WITH OTHER HYPOTHALAMIC HORMONES ON THE RELEASE OF ANTERIOR PITUITARY HORMONES (1986) (36)
- Uptake of iodinated luteinizing hormone releasing hormone analogs in the pituitary. (1977) (36)
- Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD 168368. (1999) (36)
- Regulation of acid secretion by bombesin/GRP neurons of the gastric fundus. (1991) (35)
- Breakdown of enkephalin and endorphin analogs by brain extracts (1977) (35)
- A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells. (2001) (35)
- Effects of an enkephalin analog on complex learning in the rhesus monkey (1979) (35)
- Suppression of postovulatory gonadotropin levels does not affect corpus luteum function in rhesus monkeys. (1983) (35)
- A structure–function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists (2015) (35)
- The pharmacology of endorphin modulation of chick distress vocalization (1984) (35)
- Development of Bombesin Analogs with Conformationally Restricted Amino Acid Substitutions with Enhanced Selectivity for the Orphan Receptor Human Bombesin Receptor Subtype 3 (2004) (35)
- Control of gonadotrophic hormone release in trout: influence of synthetic LH-RH and LH-RH analogues in vivo and in vitro. (1981) (34)
- Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo. (1997) (34)
- Modulation by galanin of growth hormone and gonadotropin secretion from perifused pituitary and median eminence of prepubertal male calves. (1997) (34)
- Systemic administration of endorphins selectively alters open field behavior of rats (1978) (34)
- Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeutics. (2012) (34)
- Systemic administration of a novel octapeptide, amylin-(1---8), increases bone volume in male mice. (2000) (34)
- Entry of DSIP peptides into dog CSF: Role of physicochemical and pharmacokinetic parameters (1986) (34)
- The Wound Dressings and Their Applications in Wound Healing and Management (2019) (34)
- Analogues of growth hormone-releasing factor (1-29) amide containing the reduced peptide bond isostere in the N-terminal region. (1990) (34)
- Radioimmunoassayable N-Tyr-MIF-1-like activity in rat brain is increased by pinealectomy (1981) (33)
- Effect of human pancreatic polypeptide and its C-terminal hexapeptide on pancreatic secretion in man and in the dog. (1982) (33)
- Pituitary Adenylate Cyclase Activating Polypeptide: A Neuropeptide with Potent Inotropic and Coronary Vasodilatory Effects in Neonatal Pig Hearts (1993) (33)
- A peptide inhibitor of luteinizing hormone-releasing hormone (LH-RH). (1973) (33)
- Investigation of the role of tryptophan in the luteinizing hormone-releasing hormone. (1974) (33)
- Activity of VIP, somatostatin and other peptides in the mouse vas deferens assay (1978) (33)
- GRP-receptor-mediated signal transduction, gene expression and DNA synthesis in the human pancreatic adenocarcinoma cell line HPAF (2001) (33)
- Structural requirements at the N-terminus of urotensin II octapeptides (2002) (33)
- N-Methyl scan of somatostatin octapeptide agonists produces interesting effects on receptor subtype specificity. (2001) (32)
- Anovulatory effect of a LHRH antagonist in women. (1981) (32)
- Short chain bombesin pseudopeptides with potent bombesin receptor antagonist activity in rat and guinea pig pancreatic acinar cells. (1990) (32)
- An adjustable release rate linking strategy for cytotoxin-peptide conjugates. (2003) (32)
- GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro. (1997) (32)
- Role of Different Bombesin Receptor Subtypes Mediating Contractile Activity in Cat Upper Gastrointestinal Tract (1998) (32)
- Small cell lung cancer bombesin receptors are antagonized by reduced peptide bond analogues. (1989) (32)
- Structure-activity studies on the N-terminal region of glucagon. (1984) (32)
- Amelioration of Hypoglycemia Via Somatostatin Receptor Type 2 Antagonism in Recurrently Hypoglycemic Diabetic Rats (2013) (31)
- Solid-phase synthesis of porcine vasoactive intestinal peptide. (2009) (31)
- Inhibition of growth of a prolactin-secreting pituitary tumor in rats by analogs of luteinizing hormone-releasing hormone and somatostatin. (1983) (31)
- Luteinizing hormone-releasing hormone analogs with increased anti-ovulatory activity. (1981) (31)
- Somatostatin receptor subtype 3 mediates the inhibitory action of somatostatin on gastric smooth muscle cells. (1995) (31)
- Low doses of naloxone and MIF-1 peptides increases fluid consumption in rats (1981) (31)
- [Leu13-ψ(CH2NH)Leu14]bombesin is a specific bombesin receptor antagonist in Swiss 3T3 cells (1988) (31)
- Development of Simplified Vasoactive Intestinal Peptide Analogs with Receptor Selectivity and Stability for Human Vasoactive Intestinal Peptide/Pituitary Adenylate Cyclase-Activating Polypeptide Receptors (2005) (31)
- The Histone Deacetylase Inhibitor Vaproic Acid Induces Cell Growth Arrest in Hepatocellular Carcinoma Cells via Suppressing Notch Signaling (2015) (31)
- Stimulation of luteinizing hormone (LH) and follicle-stimulating hormone by (D-Leu6, des-Gly10-NH2)-LH-releasing hormone ethylamide after subcutaneous, intravaginal, and intrarectal administration to women. (1977) (30)
- Effects of endorphin and enkephalin analogs on fear habituation in goldfish (1978) (30)
- Activation of Somatostatin Receptor Subtype 2 Inhibits Insulin Secretion in the Isolated Perfused Human Pancreas (2003) (30)
- Effect of simple amino acid replacements on the biological activity of luteinizing hormone-releasing hormone. (1973) (30)
- Caudal hindbrain neuromedin B-preferring receptors participate in the control of food intake. (1997) (30)
- Reduction of LH-RH pituitary and estradiol uterine binding sites by a superactive analog of luteinizing hormone-releasing hormone. (1980) (30)
- Bombesin stimulates adhesion, spreading, lamellipodia formation, and proliferation in the human colon carcinoma Isreco1 cell line. (1999) (30)
- Mu and delta opiate receptors in rat brain are affected by GTP but not by MIF-1 (1981) (30)
- A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9. (2007) (30)
- Effect of reductive alkylation of D-lysine in position 6 on the histamine-releasing activity of luteinizing hormone-releasing hormone antagonists. (1987) (30)
- Synthesis and biological activity of LH-RH antagonists modified in position 1 (1982) (30)
- Urethane-induced somatostatin mediated inhibition of gastric acid: reversal by the somatostatin 2 receptor antagonist, PRL-2903. (1999) (29)
- The antigenic determinant of the LH-releasing hormone for three different antisera. (1975) (29)
- Effect of substance P/bombesin antagonists on the release of growth hormone by GHRP and GHRH. (1991) (29)
- Tyrosine 220 in the 5th Transmembrane Domain of the Neuromedin B Receptor Is Critical for the High Selectivity of the Peptoid Antagonist PD168368* (2001) (29)
- Comparative Pharmacology of Bombesin Receptor Subtype-3, Nonpeptide Agonist MK-5046, a Universal Peptide Agonist, and Peptide Antagonist Bantag-1 for Human Bombesin Receptors (2013) (29)
- Rat and guinea pig pancreatic acini possess both VIP(1) and VIP(2) receptors, which mediate enzyme secretion. (2000) (29)
- [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo. (1991) (29)
- Pituitary adenylate cyclase-activating polypeptide is a potent broad-spectrum antimicrobial peptide: Structure-activity relationships (2018) (29)
- Inhibition of gastric acid secretion in rat stomach by PACAP is mediated by secretin, somatostatin, and PGE2 (2000) (29)
- Degradation of delta sleep inducing peptide (DSIP) and its analogs by brain extracts (1977) (29)
- Rat melanin concentrating hormone does not modify the release of CRH-41 from rat hypothalamus or ACTH from the anterior pituitary in vitro. (1990) (29)
- Facilitation of sexual receptivity in the rat by an ovulation-inhibiting analog of LHRH (1981) (28)
- Antitumor and antiangiogenic effects of somatostatin receptor-targeted in situ radiation with (111)In-DTPA-JIC 2DL. (2001) (28)
- Delta-sleep-inducing peptide reduces CRF-induced corticosterone release. (1985) (28)
- Targeted Chemotherapy Using a Cytotoxic Somatostatin Conjugate to Inhibit Tumor Growth and Metastasis in Nude Mice (2008) (28)
- D-amphetamine-induced hypothermia and hypermotility in rats: Changes after systemic administration of beta-endorphin (1980) (28)
- Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II (2013) (28)
- Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide–drug conjugate via activating somatostatin receptor type II (2016) (28)
- [Des-Met14]Bombesin analogues function as small cell lung cancer bombesin receptor antagonists (1991) (28)
- Radioimmunoassay of MIF-1/Tyr-MIF-1-like material in rat pineal (1980) (28)
- The effects of an LH-RH antagonist ([N-Ac-D-Trp(1)(3), D-p-Cl-Phe(2), D-Phe(6), D-Ala(10)]-LH-RH) during the preovulatory period of the rhesus monkey. (1981) (27)
- Stimulation of growth hormone by vasoactive intestinal polypeptide in acromegaly. (1984) (27)
- Comparison of the gastric exocrine inhibitory activities and plasma kinetics of somatostatin-28 and somatostatin-14 in cats (1982) (27)
- Identification of the neurotransmitter/neuromodulator functions of the neuropeptide gastrin-releasing peptide in the porcine antrum, using the antagonist (Leu13-psi-CH2 NH-Leu14)-bombesin. (1990) (27)
- Polyfluoroalkylamine derivatives of luteinizing hormone-releasing hormone. (1975) (27)
- Delta sleep-inducing peptide (DSIP)-like material is absorbed by the gastrointestinal tract of the neonatal rat. (1983) (27)
- Modulation of secretin release by neuropeptides in secretin-producing cells. (1998) (27)
- μ-Opiate binding and morphine antagonism by octapeptide analogs of somatostatin (1987) (27)
- Gonadotropin-releasing activity of two highly active and long-acting analogs of luteinizing hormone-releasing hormone after subcutaneous, intravaginal, and oral administration. (1975) (27)
- Role of pancreatic polypeptide in the regulation of pancreatic exocrine secretion in dogs. (1988) (26)
- Receptor-mediated uptake of GnRH agonist and antagonists by cultured gonadotropes: Evidence for differential intracellular routing (1986) (26)
- Effect of enkephalin and naloxone on gastric acid and serum gastrin and pancreatic polypeptide concentrations in humans. (1983) (26)
- Inhibition of luteinizing hormone release by analogs of luteinizing hormone-releasing hormone (LHRH) in vitro. (1976) (26)
- The use of growth hormone-releasing hormone in the diagnosis and treatment of short stature. (1985) (26)
- Effect of synthetic human pancreatic growth hormone-releasing factors on plasma growth hormone concentrations in lactating cows. (1984) (25)
- HYPOTHALAMIC HORMONE INTERACTION IN ACROMEGALY (1975) (25)
- Selectivity for binding of peptide analogs to vascular receptors for vasoactive intestinal peptide. (1990) (25)
- Differential effects of neuropeptides on short-term memory in primates (1981) (25)
- The disappearance, excretion, and metabolism of tritiated prolyl-leucyl-glycinamide in man. (1974) (25)
- Stimulation of growth hormone release in anesthetized and conscious pigs by synthetic human pancreatic growth hormone-releasing factor [hpGRF(1-29)-NH2] (1985) (25)
- Effects of Camptothecin Conjugated to a Somatostatin Analog Vector on Growth of Tumor Cell Lines in Culture and Related Tumors in Rodents (2004) (24)
- Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): Affinities, potencies and selectivity in multiple native and BnR transfected cells (2010) (24)
- Pituitary adenylate cyclase-activating polypeptide stimulates cholecystokinin secretion in STC-1 cells. (1996) (24)
- CHAPTER 26 – Multiple Independent Actions of Neuropeptides on Behavior (1981) (24)
- Camptothecin-somatostatin conjugates inhibit the growth of small cell lung cancer cells (2005) (24)
- Effects of β-(Tyr9)melantropin-(9–18) decapeptide on passive and active avoidance behavior and on open-field activity of rats (1981) (24)
- Intracisternal injection of somatostatin receptor 5-preferring agonists induces a vagal cholinergic stimulation of gastric emptying in rats. (2000) (24)
- Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells (2006) (24)
- Analgesia after peripheral administration of enkephalin and endorphin analogues (1979) (24)
- Luteinizing hormone releasing hormone. Solid-phase synthesis of a 5-phenylalanine analog possessing high biological activity. (1973) (23)
- MIF-I and postsynaptic receptor sites for dopamine (1979) (23)
- In vitro inhibition of LH release by a synthetic antagonist of LH-releasing hormone (LH-RH). (1974) (23)
- Reduced peptide bond pseudopeptide analogues of substance P. A new class of substance P receptor antagonists with enhanced specificity. (1989) (23)
- Reduced gastric acid inhibitory effect of a pGIP(1–30)NH2 fragment with potent pancreatic amylase inhibitory activity (1992) (23)
- Growth hormone responses to growth hormone-releasing hormine (1–29)-NH2 and a D-Ala2 analog in normal men (1985) (23)
- Convenient apparatus for preparative polyacrylamide gel electrophoresis and its use in purification of three porcine neurophysins. (1971) (23)
- Human growth hormone-releasing hormone analogues with much improved in vitro growth hormone-releasing potencies in rat pituitary cells. (1991) (23)
- Effect of somatostatin on gastrointestinal secretions and peptic ulcer production in cats. (1977) (23)
- Comparative structural requirements of thirty GRF analogs for interaction with GRF- and VIP receptors and coupling to adenylate cyclase in rat adenopituitary, liver and pancreas (1986) (22)
- Comparison of Somatuline (BIM‐23014) and somatostatin on endocrine and exocrine activities in the rat (1991) (22)
- Pituitary adenylate cyclase-activating peptide stimulates rat pancreatic secretion via secretin and cholecystokinin releases. (1998) (22)
- HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor II. (2018) (22)
- An in vivo assay for anti-LH-RH and anti-FSH-RH activity of inhibitory analogues of LH-RH. (1975) (22)
- Synthesis and biological properties of the 2-L-beta-(pyrazolyl-1)alanine analogs of luteinizing hormone-releasing hormone and thyrotropin-releasing hormone. (1975) (22)
- Comparison of responses to rat and human adrenomedullin in the hindlimb vascular bed of the cat (1997) (22)
- Adrenomedullin attenuates pressor response to angiotensin II in conscious sheep. (2000) (22)
- Covalently cyclized agonist and antagonist analogues of bombesin and related peptides. (1991) (22)
- Structure-Activity Relationships of Glucose-Dependent Insulinotropic Polypeptide (GIP) (2003) (22)
- Receptor binding and adenylate cyclase activities of glucagon analogues modified in the N-terminal region. (1986) (22)
- (D‐Phe12) bombesin and substance P analogues function as central bombesin receptor antagonists (1988) (22)
- Analogs of luteinizing hormone-releasing hormone containing derivatives of phenylalanine in place of tyrosine. (1973) (22)
- Radioautographic localization of radioactivity in rat brain after intraventricular or intracarotid injection of 3H-L-prolyl-L-leucyl glycinamide (1975) (22)
- Endogenous opiates: 1979 (1980) (22)
- Galanin: structure-dependent effect on pancreatic amylase secretion and jejunal strip contraction. (1993) (22)
- Possible non-narcotic component to action of opiate peptides on tonic immobility (1979) (22)
- Differential effects of N-terminal modifications on the biological potencies of growth hormone releasing factor analogues with varying chain lengths. (1987) (22)
- Human pancreatic polypeptide inhibits insulin release in the rat. (1981) (21)
- Effect of the CH2NH and CH2NAc peptide bond isosteres on the antagonistic and histamine releasing activities of a luteinizing hormone-releasing hormone analogue. (1988) (21)
- Somatostatin and analogs inhibit endogenous synaptic plasma membrane protein phosphorylation in vitro. (1983) (21)
- Effects of somatostatin and a somatostatin agonist on diet-induced pancreatitis in mice (1985) (21)
- Partial agonist activity of the bombesin-receptor antagonist [Leu14-psi-CH2-NH-Leu13]-bombesin in frog peptic cells. (1988) (21)
- Increased and prolonged LH-RH/FSH-RH activity of synthetic (D-Ala6, Des-Gly-NH210)-LH-RH-ethylamide in normal women. (1975) (21)
- Vasoactive intestinal peptide reduces oxidative stress in pancreatic acinar cells through the inhibition of NADPH oxidase (2011) (21)
- Bombesin-like peptides stimulate somatostatin release from rat fundic D cells in primary culture. (1997) (21)
- Expression of somatostatin receptor genes and their role in inhibiting Cl- secretion in HT-29cl.19A colonocytes. (1995) (21)
- Inhibition by six somatostatin analogs of plasma growth hormone levels stimulated by thiamylal and morphine in the rat (1976) (21)
- Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes. (1995) (21)
- Gastrin-releasing peptide is a transmitter mediating porcine gallbladder contraction. (1991) (21)
- Molecular Basis for Agonist Selectivity and Activation of the Orphan Bombesin Receptor Subtype 3 Receptor (2008) (21)
- Identification of Bombesin Receptor Subtype-Specific Ligands: Effect of N-Methyl Scanning, Truncation, Substitution, and Evaluation of Putative Reported Selective Ligands (2006) (21)
- Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure. (2002) (20)
- Inhibition of the postcastration rise of luteinizing hormone and follicle-stimulating hormone in female rhesus monkeys (Macaca mulatta) by the administration of a luteinizing hormone-releasing hormone inhibitory analog ([N-Ac-D-Trp1-3,D-p-Cl-phe2,D-Phe6,D-Ala10]-LH-RH). (1981) (20)
- Galanin inhibits pancreatic amylase secretion in the pentobarbital-anesthetized rat (1991) (20)
- Responses to human CGRP, ADM, and PAMP in human thymic arteries. (2003) (20)
- Inhibitory effect of galanin on basal and pentagastrin-stimulated gastric acid secretion in rats. (1990) (20)
- SSTR2 mediates the somatostatin-induced increase in intracellular Ca(2+) concentration and insulin secretion in the presence of arginine vasopressin in clonal beta-cell HIT-T15. (2002) (20)
- Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP). (2005) (20)
- Vasoactive intestinal peptide–camptothecin conjugates inhibit the proliferation of breast cancer cells (2007) (20)
- Behavioral effects after systemic injection of opiate peptides (1980) (20)
- [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release. (1980) (20)
- Characterization of bombesin binding sites in the rat stomach. (1997) (20)
- Effects of camptothecin on tumor cell proliferation and angiogenesis when coupled to a bombesin analog used as a targeted delivery vector (2007) (20)
- Somatostatin receptor-mediated signaling in smooth muscle. Activation of phospholipase C-beta3 by Gbetagamma and inhibition of adenylyl cyclase by Galphai1 and Galphao. (1996) (20)
- Serum gonadotropin concentrations and ovarian response in ewes treated with analogs to LH-RH/FSH-RH. (1976) (20)
- Potent, highly selective inhibition of growth hormone secretion by position 4 somatostatin analogs. (1981) (20)
- Bombesin receptor antagonists differentiate receptor subtypes in rat brain. (1993) (20)
- Autoradiographic localization of neuromedin B binding sites in rat brain (1990) (20)
- Synthesis and biological properties of ovine corticotropin-releasing factor (CRF). (1982) (20)
- Brain β-endorphin-like immunoreactivity in adult rats given β-endorphin neonatally (1981) (20)
- Analysis of responses to hAmylin, hCGRP, and hADM in isolated resistance arteries from the mesenteric vascular bed of the rat (2001) (19)
- Blockade of LH release and ovulation in the rabbit with inhibitory analogues of luteinizing hormone releasing hormone. (1977) (19)
- Disappearance and excretion of labeled α-MSH in man (1978) (19)
- Sleep-wave activity of a delta sleep-inducing peptide analog correlates with its penetrance of the blood-brain barrier. (1986) (19)
- Cyclic analogues of luteinizing hormone-releasing hormone with significant biological activities. (1978) (19)
- Suppressive effect of an inhibitory LHRH analog on the gonadotropin response to LHRH in normal women. (1980) (19)
- Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2 (2017) (19)
- Role of vagal fibers and bombesin/gastrin-releasing peptide-neurons in distention-induced gastrin release in rats (1997) (19)
- Proadrenomedullin NH2-terminal 20 peptide (PAMP) and adrenomedullin bind to teratocarcinoma cells☆ (2000) (19)
- Distribution of radioactivity in the organs of the rat and mouse after injection of L-(3H)prolyl-L-leucyl-glycinamide. (1975) (19)
- Bombesin receptor subtype mediation of gastroenteropancreatic hormone secretion in rats (1994) (19)
- Distinct receptors mediate gastrin-releasing peptide and neuromedin B-induced delay of gastric emptying of liquids in rats (1995) (19)
- Production of immunoreactive pituitary adenylate cyclase activating polypeptide (PACAP) by human neuroblastoma cells, IMR-32: detection and characterization with monoclonal and polyclonal antibodies against different epitopes of PACAP. (1993) (19)
- Serum LH, FSH and testosterone response to the administration of a new LH-RH analog, D-Trp6-LH-RH, in normal men. (1977) (19)
- Evidence for conversion of N-Tyr-MIF-1 into MIF-1 by a specific brain aminopeptidase (1984) (19)
- Minimal side-chain protection can be a successful strategy in solid-phase peptide synthesis. (2009) (19)
- Abilities of 3,4-diarylfuran-2-one analogs of combretastatin A-4 to inhibit both proliferation of tumor cell lines and growth of relevant tumors in nude mice. (2004) (18)
- Proadrenomedullin NH2-terminal 20 peptide has direct vasodilator activity in the cat. (1997) (18)
- Comparison of the anti-LH/FSH-RH and anti-ovulatory activities of (D-Phe2, D-Leu6)-LH-RH and (D-Phe2, D-Ala6)-LH-RH. (1976) (18)
- In Vitro Histamine Release with LHRH Analogs (1987) (18)
- Branched-chain analogues of luteinizing hormone-releasing hormone. (1978) (18)
- Pituitary adenylate cyclase-activating polypeptide prevents contrast-induced nephropathy in a novel mouse model (2013) (18)
- Fourth ventricular injection of the bombesin receptor antagonist [d-phe6]bombesin(6–13)methyl ester, but not BW2258U89, increases food intake in rats (1995) (18)
- The Effect of Oral and Vaginal Administration of Synthetic LH-RH and [D-ALA6, DES GLY10-NH2]-LH-RH Ethylamide on Serum LH Levels in Ovariectomized, Steroid Blocked Rats 1 (1975) (18)
- GI side-effects of a possible therapeutic GRF analogue in monkeys are likely due to VIP receptor agonist activity (2001) (18)
- Inhibition of gastric acid secretion in rat stomach by PACAP is mediated by secretin, somatostatin, and PGE(2). (2000) (18)
- Tyrosine-modified analogs of methionine-enkephalin and their effects on the mouse vas deferens (1980) (18)
- Blockade of ovulation in rats by inhibitory analogs of luteinizing hormone-releasing hormone (1976) (18)
- STUDY OF INHIBITORY EFFECTS OF AN ANTIANGIOGENIC SOMATOSTATIN-CAMPTOTHECIN CONJUGATE ON LASER-INDUCED CHOROIDAL NEOVASCULARIZATION IN RATS (2005) (17)
- Peptides and the Blood-Brain Barrier (1980) (17)
- STIMULATION OF LUTEINISING HORMONE (L.H.) RELEASE AFTER ORAL ADMINISTRATION OF AN ANALOGUE OF L.H. RELEASING HORMONE (1975) (17)
- Structural requirements for galanin inhibition of pentagastrin-stimulated gastric acid secretion in conscious rats. (1992) (17)
- Solid-phase synthesis and biological activities of gastrointestinal hormones: Secretin and motilin (1982) (17)
- Effects of a novel bombesin antagonist analogue on bombesin-stimulated gastric acid secretion and growth hormone release in the pentobarbital-anesthetized rat. (1989) (17)
- Bombesin, neuromedin B and neuromedin C interact with a common rat pancreatic phosphoinositide-coupled receptor, but are differentially regulated by guanine nucleotides. (1991) (17)
- Suppression of the positive feedback of estradiol benzoate on gonadotropin secretion by an inhibitory analog of luteinizing hormone-releasing hormone (LRH) in oophorectomized rhesus monkeys: evidence for a necessary synergism between LRH and estrogens. (1983) (17)
- Smooth muscle cells from guinea pig stomach possess high-affinity galanin receptors that mediate relaxation. (1994) (17)
- Systematic development of bombesin/gastrin-releasing peptide antagonists. (1992) (17)
- [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes. (1987) (17)
- Naloxone-reversible effects of d-Ala2-Met5-enkephalinamide-induced behavioral activity in rats. (1980) (16)
- Somatostatin analogues and multiple receptors: possible physiological roles. (1995) (16)
- Colonic smooth muscle cells possess a different subtype of somatostatin receptor from gastric smooth muscle cells. (1997) (16)
- Superactive amidated COOH-terminal glucagon analogues with no methionine or tryptophan (1986) (16)
- Purification and amino acid composition of constituents of rat neurophysin. (1972) (16)
- Three-dimensional quantitative structure-activity relationships of somatostatin analogues. 1. Comparative molecular field analysis of growth hormone release-inhibiting potencies. (1995) (16)
- Prolonged elevation of luteinizing hormone (LH) after intranasal administration of an analog of LH-releasing hormone. (1976) (16)
- DSIP reduces amphetamine-induced hyperthermia in mice (1984) (16)
- LHRH antagonists in females (1984) (16)
- Experiments with a reported anorexigenic tripeptide: PyroGluHisGlyOH (1979) (15)
- Effect of [D-Phe6] bombesin (6-13) methylester, a bombesin receptor antagonist, towards bombesin-induced contractions in the guinea-pig and rat isolated urinary bladder. (1992) (15)
- Anti-Luteinizing Hormone (LH)-Releasing Activity of Several Analogues of LH-Releasing Hormone (1975) (15)
- Clinical studies with d-TRP6-luteinizing hormone-releasing hormone in men with hypogonadotropic hypogonadism. (1978) (15)
- Gliclazide directly inhibits arginine-induced glucagon release. (2002) (15)
- Cytotoxic conjugates of peptide hormones for cancer chemotherapy (2008) (15)
- STIMULATORY AND INHIBITORY ANALOGS OF LH-RH (1981) (15)
- Novel urotensin II (UII) antagonists point to multiple receptor involvement in UII bioactivity (2000) (15)
- Direct and indirect inhibition of ovulation in rats by an antagonist of luteinizing hormone-releasing hormone. (1985) (15)
- Conformational study of super-active analogues of somatostatin with reduced ring size by XXXH nmr (1988) (15)
- Dissociation of the effects of amylin on osteoblast proliferation and bone resorption. (1998) (15)
- Increased potency of four analogues of LH-releasing hormone in man. (1974) (15)
- GRP-preferring bombesin receptor subtype mediates contractile activity in cat terminal ileum (1994) (14)
- Multiply radioiodinated somatostatin analogs induce receptor-specific cytotoxicity. (1998) (14)
- Pharmacokinetic evaluation of superactive analogues of growth hormone-releasing factor (1–29)-amide (1988) (14)
- Is Notch Signaling a Specific Target in Hepatocellular Carcinoma? (2015) (14)
- Effects of an LHRH antagonist on the time of occurrence and amplitude of the preovulatory LH surge, progesterone and estradiol secretion, and ovulation in superovulated Holstein heifers. (1994) (14)
- Selective effect of some somatostatin analogs on glucagon as opposed to insulin release in rats in vivo. (1980) (14)
- Comparison of TRH and anorexigenic peptide on food intake and gastrointestinal secretions (1981) (14)
- Galanin inhibits cholecystokinin secretion in STC-1 cells. (1995) (14)
- Activation of human somatostatin receptor type 2 causes inhibition of cell growth in transfected HEK293 but not in transfected CHO cells. (1997) (14)
- Attempts to programme ovulation with exogenous oestrogens and LH-RH analogue. (1975) (14)
- Somatostatin Receptor-mediated Signaling in Smooth Muscle ACTIVATION OF PHOSPHOLIPASE C- 3 BY G AND INHIBITION OF ADENYLYL CYCLASE BY G AND G o (1996) (14)
- Is the postovulatory release of follicle-stimulating hormone in the rabbit mediated by luteinizing hormone-releasing hormone? (1983) (14)
- Suppression of LH-RH-induced ovulation in hamsters and rats by synthetic analogues of LH-RH. (1976) (14)
- ANALOGS OF LUTEINIZING HORMONE-RELEASING HORMONE WITH INCREASED BIOLOGICAL ACTIVITY PRODUCED BY D-AMINO ACID SUBSTITUTIONS IN POSITION 6 (1976) (14)
- Autoradiographic evidence that zona glomerulosa and capsular vessels of the human adrenal cortex are provided with different subtypes of adrenomedullin receptors (1998) (14)
- Receptor occupancy and adenylate cyclase activation in rat liver and heart membranes by 10 glucagon analogs modified in position 2, 3, 4, 25, 27 and/or 29 (1988) (14)
- Interaction of ovine pituitary adenylate cyclase-activating peptide (PACAP-38) with rat lung membranes (1993) (14)
- Metabolism of potent enkephalin analogs (FK 33–824, D-Ala2, pentafluorophenylalanine-4-enkephalinamide and a dimer of D-Ala2-enkephalin) and D-amino acid substituted derivatives of human β-endorphin (1978) (13)
- Galanin-induced relaxation in gastric smooth muscle cells is mediated by cyclic AMP (1994) (13)
- COMPARISON OF LONG‐ACTING ANALOGUES OF LUTEINIZING HORMONE RELEASING HORMONE IN MAN (1979) (13)
- Somatostatin inhibits insulin release via SSTR2 in hamster clonal β-cells and pancreatic islets (2005) (13)
- Synthesis and biological properties of (2-L-beta-(pyrazolyl-3)alanine)-luteinizing hormone-releasing hormone. (1974) (13)
- Somatostatin‐receptor 2 (sst2)‐mediated effects of endogenous somatostatin on exocrine and endocrine secretion of the rat stomach (2005) (13)
- Cyclic lactam analogues of ovine pituitary adenylate cyclase activating polypeptide (PACAP): Discovery of potent type II receptor antagonists (1994) (13)
- Administration of human pancreatic growth hormone-releasing factor (GRF) analogs enhances responsiveness of cultured rat pituitary cells to GRF. (1984) (13)
- Basic and clinical studies with luteinizing hormone-releasing hormone (LH-RH) and its analogues. (1973) (13)
- Comparison of enkephalin and atropine in the inhibition of vagally stimulated gastric and pancreatic secretion and gastrin and pancreatic polypeptide release in dogs (1982) (13)
- Structure-CNS activity studies with the enkephalins. (1980) (13)
- Stereoisomers of luteinizing hormone-releasing hormone. (1974) (13)
- Effects of secretin and gastric inhibitory polypeptide on human pancreatic growth hormone-releasing factor(1-40)-stimulated growth hormone levels in the rat. (1983) (13)
- Administration of luteinizing hormone-releasing hormone analogs delays ovulation without affecting the luteal function in rhesus monkeys. (1983) (13)
- Strategies in the design of synthetic agonists and antagonists of growth hormone releasing factor (1986) (13)
- Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes (2016) (13)
- Effects of MIF-1 and three related peptides on reserpine-induced hypothermia in mice (1981) (13)
- Inhibitory effect of somatostatin-28 on pancreatic polypeptide, glucagon and insulin secretion in normal man. (1983) (13)
- Effects of anorexigenic peptide on gastric and pancreatic secretion. (1981) (13)
- Behavioral effects of D-Ala2-β-endorphin in squirrel monkeys (1978) (13)
- A multi-tyrosinated sst1/2 receptor preferring somatostatin agonist inhibits reflex and immune-mediated secretion in the guinea pig colon (2003) (12)
- Unusual dose-related effect of an endorphin analog in a complex maze (1980) (12)
- Bombesin receptor antagonists: different classes and cellular basis of action. (1993) (12)
- Bombesin Analogues Inhibit Growth of Small Cell Lung Cancer in Vitro and in Vivo 1 (2006) (12)
- An in vivo model for testing inhibition of arginine-induced insulin and glucagon release by somatostatin analogs. (1977) (12)
- Synthesis and characterization of multiply-tyrosinated, multiply-iodinated somatostatin analogs. (1999) (12)
- Investigation of cancer cell lines for peptide receptor-targeted drug development (2011) (12)
- Clinical comparison of natural LH-RH, synthetic LH-RH, and two analogues of LH-RH. (1974) (12)
- Tyr-MIF-1 affects passive avoidance behavior but not motor activity in rats (1983) (12)
- Inverse relationship between onset and duration of EEG effects of six peripherally administered peptides (1981) (12)
- Psychopharmacological and endocrinological effects of melanocyte stimulating hormones in normal man (1977) (12)
- Prolonged inhibition of growth hormone secretion by peripheral injection of bombesin is mediated by somatostatin in the rat. (1985) (12)
- Plasma Progestins in Anestrous Ewes Treated with D-Leu Des GlyNH -LHRH Ethylamide (1977) (12)
- Intracerebroventricular injection of somatostatin sst5 receptor agonist inhibits gastric acid secretion in rats. (1996) (12)
- New reduced peptide bond substance P agonists and antagonists: effects on smooth muscle contraction. (1991) (12)
- Pharmacological characterization of [Leu-13-psi-CH2NH-Leu14]-bombesin as a specific bombesin receptor antagonist on isolated smooth muscle cells. (1989) (12)
- Inhibition of pancreatic secretion by enkephalin and morphine in dogs. (1978) (12)
- Identification and initial characterization of a putative neuromedin B-type receptor from rat urinary bladder membranes. (1992) (12)
- Inhibition of release in the baboon by inhibitory analogs of lutheinizing hormone releasing hormone. (1977) (12)
- Parellel inhibition of LH-RH-induced cyclic AMP accumulation and LH and FSH release by LH-RH antagonists in vitro. (1975) (12)
- Systemic injections of gastro-intestinal peptides alter behavior in rats (1980) (11)
- Effects of an LHRH antagonist on gonadotrophin and oestradiol secretion, follicular development, oestrus and ovulation in Holstein heifers. (1989) (11)
- The effect of treatment with an LHRH antagonist on the quality of day-7 embryos collected from superovulated Holstein heifers (1990) (11)
- Actions of somatostatins on gastric smooth muscle cells. (1992) (11)
- Bioactivity of growth hormone releasing hormone (1–29) analogues after SC injection in man (1989) (11)
- Structure-Activity Relationship of LH and FSH Releasing Hormone (1975) (11)
- Development of a method to test anti-LH-RH activity in rats. (1974) (11)
- Isolation, structure, biological characterization, and synthesis of beta-[Tyr9]melanotropin-(9-18) decapeptide from pig hypothalami. (1980) (11)
- ANALOGUES OF GROWTH-HORMONE RELEASE-INHIBITING HORMONE (1975) (11)
- Improved antagonists of luteinizing hormone-releasing hormone modified in position 7. (1985) (11)
- Comparative efficacy of seven synthetic glucagon analogs, modified in position 1, 2 and/or 12, on liver and heart adenylate cyclase from rat (1986) (10)
- Selective Inhibition of Glucagon and Insulin Secretion by Somatostatin Analogs 1 (1979) (10)
- LH-RH antagonists: Further analogs with ring-substituted aromatic residues (1981) (10)
- Conformational study of somatostatin analogues in methanol at low temperature (1991) (10)
- 1 – Hypothalamic Peptide Hormones: Basic and Clinical Studies (1979) (10)
- CNS ACTIONS OF PERIPHERALLY ADMINISTERED PEPTIDES: SOME UNRESOLVED ISSUES (1982) (9)
- [D-Ala2,(F5)Phe4]-dynorphin1–13-NH2 (DAFPHEDYN): A potent analog of dynorphin 1–13 (1987) (9)
- Influence of LH-RH agonists and antagonists on gonadotropin release in humans. (1980) (9)
- Response of luteinizing hormone and follicle-stimulating hormone to different doses of D-leucine-6-LH-RH ethylamide in oligospermic patients. (1976) (9)
- Antagonistic activity of analogs of luteinizing hormone-releasing hormone (LH-RH) in vitro (1976) (9)
- Effect of a powerful antagonist of LH-RH on testicular function in prepubertal male rats. (1983) (9)
- Correlation between in vivo inhibition of gonadotropin release induced by LH-RH and the blockade of ovulation by synthetic analogues of LH-RH. (1978) (9)
- Suppression of gonadotropin release and ovulation in animals by inhibitory analogs of luteinizing hormone-releasing hormone. (1976) (9)
- Influence of intracisternal injection of somatostatin analog receptor subtypes 2, 3 and 5 on gastric acid secretion in conscious rats (1995) (9)
- Adenohypophyseal response to hypophysiotropic hormones in male obese Zucker rats. (1985) (9)
- Isolation, structure and synthesis of a heptapeptide with in vitro ACTH-releasing activity from porcine hypothalamus. (1981) (9)
- The effect of drug dose and drug exposure time on the binding, internalization, and cytotoxicity of radiolabeled somatostatin analogs. (2004) (9)
- Prolonged anti-luteinizing hormone/follicle-stimulating hormone-releasing activities of some synthetic antagonists of luteinizing hormone-releasing hormone. (1976) (9)
- LH-RH antagonist inhibits gonadal steroid secretion in vitro (1985) (9)
- Inhibition of bombesin-stimulated gastrin release from isolated canine G cells by bombesin antagonists. (1989) (9)
- Organ removal and disappearance half-time of synthetic human pancreatic polypeptide. (1982) (9)
- Opposite effects of CRF and ACTH on reserpine-induced hypothermia (1982) (9)
- Distinguishing bombesin receptor subtypes using the oocyte assay. (1991) (9)
- Inhibition of bombesin-stimulated gastrin release from isolated human G cells by bombesin analogs. (1990) (9)
- Clinical studies with d-Trp 6-luteinizing hormone-releasing hormone in anovulatory women. (1978) (9)
- Antagonism of ethanol induced sleep-time by alpha-msh, MSH/ACTH4-10 and naloxone. (1980) (9)
- Inhibition of the release of growth hormone in vitro by -melanocyte stimulating hormone. (1973) (9)
- Exploration of the DTrp-NMeLys motif in the search for potent somatostatin antagonists. (2002) (8)
- Inhibition of Sham Feeding-Induced Gastric Secretion and Serum Hormonal Responses by Analogs of (pyro)Glu-His-Gly-OH (1982) (8)
- Effects of β-/Tyr9/melanotropin-/9–18/ decapeptide on catecholamine disappearance and serotonin accumulation in discrete brain regions of rats (1981) (8)
- Effect of bombesin antagonist D-Phe6-BN(6-13)OMe on vagally induced gastrin release from perfused rat stomach. (1993) (8)
- Effect of [(CH2NH)4,5]secretin on pancreatic exocrine secretion in guinea pigs and rats. (1993) (8)
- Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion. (1989) (8)
- DSIP-like immunoreactivity in the developing rat brain (1981) (8)
- Synthesis of luteinizing hormone-releasing hormone containing tritium-labelled pyroglutamic acid. (1973) (8)
- Cyclic hexa- and pentapeptide somatostatin analogues with reduced gastric inhibitory activity (1984) (8)
- Effect of enkephalin and endorphin analogs on receptors in the mouse vas deferens. (1978) (8)
- Polyfluoroalkyl derivatives of nitrogen. Part XL. Reaction of trifluoronitrosomethane with NN-bistrifluoromethylamino-substituted allenes (1973) (8)
- Blockade of bombesin receptors with [Leu14-ψ(CH2NH)-Leu13]bombesin fails to suppress nutrient-induced CCK release from rat duodenojejunum (1990) (8)
- Characteristics of [D-Trp8]-somatostatin-sensitive B50 phosphorylation (1985) (8)
- Progress in the development of competitive bombesin antagonists (1987) (8)
- Stimulatory and inhibitory analogs of luteinizing hormone releasing hormone (LHRH). (1977) (8)
- Kyotorphins affect aversive pecking in chicks (1981) (8)
- Some of the α-NH2-acetylated β-endoprhin-like material in rat and monkey pituitary and brain is acetylated α- and β-endorphin (1983) (7)
- Effect of enkephalin and naloxone on vagal and hormonal stimulation of pancreatic secretion in man. (1983) (7)
- Brain beta-endorphin-like immunoreactivity in adult rats given beta-endorphin neonatally. (1981) (7)
- Comparison of prolonged in vivo inhibitory activity of several potent bombesin (BN) antagonists on BN-stimulated amylase secretion in the rat (1991) (7)
- DNA and the Digital Data Storage (2019) (7)
- Inhibitory activity of four analogs of luteinizing hormone-releasing hormone in vivo. (1975) (7)
- Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice (2017) (7)
- Glp-1 analogue (1999) (7)
- Dynamics of injected somatostatin in blood of patients with hepatic failure and acromegaly (1980) (7)
- Anti-Convulsant Drug Valproic Acid in Cancers and in Combination Anti- Cancer Therapeutics (2014) (7)
- Blockade of the Pre-ovulatory LH Surge in Hamsters by an Inhibitory Analog of LH-RH 1 (1975) (7)
- Chief cells possess somatostatin receptors regulated by secretagogues acting through the calcium or cAMP pathway. (1994) (7)
- The interaction between β-[Tyr9]melanotropin-(9–18), haloperidol and amphetamine in different behavior tests of rats (1982) (7)
- Effects of endorphins and their analogues on prolactin and growth hormone secretion (1979) (6)
- Pituitary Response to Luteinizing Hormone- Releasing Hormone Analog at Sea Level and High Altitudes (1982) (6)
- Receptor-selective somatostatin (SRIF) analogs (1988) (6)
- Lack of growth hormone-releasing activity of (pyro)Glu-Ser-Gly-NH2. (1973) (6)
- Effects of analogs of (pyro)Glu-His-Gly-OH on food consumption and gastric acid secretion in rats. (1984) (6)
- Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients. (1983) (6)
- Poly(bistrifluoromethylamino)-compounds. Synthesis of NN-bistrifluoromethylamino-substituted allenes and their reaction with trifluoronitrosomethane (1970) (6)
- A selective somatostatin type-2 receptor agonist inhibits neointimal thickening and enhances endothelial cell growth and morphology following aortic balloon injury in the rabbit (2002) (6)
- Development of somatostatin agonists with high affinity and specificity for the human and rat type 5 receptor subtype (2002) (6)
- Administration of agonistic and antagonistic analogues of LH-RH induce anovulation in Macaca fasicularis. (1983) (6)
- Solubilization and purification of bombesin/gastrin releasing peptide receptors from human cell lines (2007) (6)
- Some analogs of Tyr-MIF-1 affect passive avoidance behavior but not motor activity in rats (1984) (6)
- Role of endogenous bombesin-peptides during vagal stimulation of gastric acid secretion in the rat (1996) (6)
- Observations on the growth hormone, insulin, and glucagon release-inhibiting activities of somatostatin analogues. (1978) (6)
- The use of pigs as an animal model to evaluate the efficacy, potency and specificity of two growth hormone releasing factor analogues. (2001) (6)
- Distribution of 3H-alpha-MSH in rat brain. (1976) (6)
- Use of the cutaneous anaphylactoid test to detect differences in mast cell mediator-releasing activity among LHRH peptides. (1987) (5)
- Effects of H-Phe-Ile-Tyr-His-Ser-Tyr-Lys-OH on passive and active avoidance behavior and on open-field activity of rats (1982) (5)
- Gonadotropin release during repeated administration of d-Leu6 des Gly10-LH-RH-EA at different stages of the menstrual cycle and in functional amenorrhea. (1980) (5)
- Thyroxine analogues: synthesis of 3,3',5,5'-tetramethyl-L-thyronine. (1972) (5)
- The use of a potent stimulatory LHRH analog (D-Trp-6, LHRH) in the induction of ovulation. (1980) (5)
- Effects of β-/Tyr9/melanotropin-/9–18/ on apomorphine-induced stereotyped cage-climbing and on striatal dopamine release in mice. Comparative studies with amphetamine (1982) (5)
- Somatostatin agonists and antagonists--peptide control of growth hormone secretion. (1985) (5)
- Levels of luteinizing hormone (LH), follicle-stimulating hormone, and 17 beta-estradiol in response to D-Trp6-LH-releasing hormone during different phases of the menstrual cycle in normal women. (1978) (5)
- Central Nervous System Effects after Systemic Injection of Opiate Peptides (1982) (5)
- Conversion of O-succinimidyl carbamates to N-(O-carbamoyl)-succinmonoamides and ureas: effects of N-substituents and reaction conditions on the reaction pathway (2002) (5)
- Temporal changes in FSH and LH concentrations following the administration of a potent LH-RH inhibitory analogue ( [N-Ac-D-Trp1, 3, D-p-Cl-Phe2, D-Phe6, D-Ala10]-LH-RH) to oophorectomized rhesus monkeys. (1983) (5)
- Synthesis and biological activity of LH-RH analogs modified at the carboxyl terminus. (1975) (5)
- Proceedings: Investigation and treatment of a recurrent vipoma. (1975) (4)
- Comparison of the inhibition of histamine-and pentagastrin-stimulated gastric acid secretion by somatostatin in the cat (1977) (4)
- The effects of β-(TYR9)melanotropin-(9–18) and H-PHE-ILE-TYR-HIS-SER-TYR-LYS-OH on the analgesic action of morphine (1983) (4)
- Specific labelling of high-affinity vasoactive intestinal peptide receptors in rat liver membranes by a growth hormone-releasing factor analog. (1986) (4)
- Effect of reductive alkylation of lysine in positions 6 and/or 8 on the histamine-releasing activity of luteinizing hormone-releasing hormone antagonists. (1987) (4)
- Systemic administration of Met-enkephalin, (D-Ala2)-Met-enkephalin, beta-endorphin, and (D-Ala2)-beta-endorphin: effects on eating, drinking and activity measures in rats. (1979) (4)
- Effect of intracerebroventricular administration of β-/Tyr9/-melanotropin-/9–18/ on rotational behavior induced by substantia nigra lesion in rats (1983) (4)
- Polyfluoroalkyl derivatives of nitrogen. Part XXXIX. Preparation of NN-bistrifluoromethylamino-substituted allenes (1973) (4)
- Use of the mouse vas deferens assay to evaluate the action of somatostatin peptides on gastric acid secretion. (1981) (4)
- Tyrosine 220 in the 5 th Transmembrane Domain of the Neuromedin B Receptor Is Critical for the High Selectivity of the Peptoid Antagonist PD 168368 * (2000) (4)
- The molecular basis for high affinity of a universal ligand for human bombesin receptor (BnR) family members. (2012) (4)
- Luteinizing hormone (LH), follicle-stimulating hormone, and testosterone responses to consecutive injections of D-leucine-6-LH-releasing hormone ethylamide in normal men. (1977) (4)
- Physiological, veterinary and clinical effects of hypothalamic releasing hormones (RH), especially LH-RH (1974) (4)
- Selective conversion of O-succinimidyl carbamates to N-(O-carbamoyl)-succinmonoamides and ureas (2002) (4)
- Attempts to induce ovulation in amenorrheic patients using D-Ala-6-LH-RH propylamide. (1979) (4)
- Effect of D-Trp6-LH-RH on the pituitary-gonadal axis during the luteal phase in the baboon. (1979) (3)
- Structure-activity studies of antagonists of luteinizing hormone-releasing hormone with emphasis on the amino-terminal region. (1987) (3)
- Solid-phase synthesis of human pancreatic polypeptide. (2009) (3)
- Synthesis of camptothecin–amino acid carbamate linkers (2012) (3)
- Effects of Administration of a LH-RH Inhibitory Analogue on Stages of the Rat Estrous Cycle 1 2 (1978) (3)
- Effect of Ala-2-D-Trp-8-D-Cys-14-somatostatin on the arginine induced release of insulin, GH and glucagon in normal men. (1984) (3)
- Structure-activity relationships for relaxation of smooth muscle by VIP (1994) (3)
- Bombesin stimulates invasion and migration of lsreco1 colorecial cancer cells in a Rho-dependent manner (2001) (3)
- Structural Analysis of Ligand Binding Characteristics for the Bombesin/Gastrin-Releasing Peptide Receptor (1993) (3)
- Long-acting luteinizing homone-releasing hormone (LH-RH) analogs in the treatment of female infertility. (1976) (3)
- Effects of CRF-like heptapeptide on catecholamine disappearance and serotonin accumulation in different brain areas of rats (1982) (3)
- Comparative structural requirements of GRF analogs for occupancy of GRF and VIP receptors and coupling to adenylate cyclase in rat adenopituitary, liver and pancreas (1985) (3)
- Polyfluoroalkyl compounds of silicon. Part X. Further silanes containing the bis(trifluoromethyl)amino-group (1974) (3)
- Effects of in vivo treatment with an LHRH antagonist analog (D-PHE2-D-PHE6) in the immature male rat. (1978) (3)
- The Opioid Neuropeptides Enkephalin and Endorphin and their Hypothesized Relation to Pain (1980) (3)
- The Pathogenesis and Therapeutics of Nasopharyngeal Carcinoma (2019) (3)
- STRUCTURE ACTIVITY STUDIES ON THE N-TERMINAL REGION OF GLUCAGON (1984) (3)
- Structure-activity studies with somatostatin: role of lysine in positions 4 and 9 for gastric activity (1984) (3)
- Application of human pancreatic carcinoid BON cells for receptor-targeted drug development (2011) (3)
- HETEROGENEITY OF HUMAN GROWTH HORMONE IN PLASMA AND URINE: INFLUENCE OF GROWTH HORMONE RELEASE INHIBITING HORMONE (1975) (3)
- Lanreotide and its Potential Applications in Polycystic Kidney and Liver Diseases. (2015) (3)
- Neurological effects of MIF-1, MSH, and opiate peptides in clinical studies. (1980) (2)
- Disapearance and excretion of labeled alpha-MSH in man. (1978) (2)
- Branched-chain analogs of luteinizing hormone-releasing hormone (1978) (2)
- Potent, short, cyclic peptide antagonists of somatostatin (SS) (1983) (2)
- Distinct receptors mediate gastrin-releasing peptide and neuromedin beta-induced delay of gastric of liquids in rats. (1995) (2)
- Dose response inhibition of the circhoral pulsatile secretion of LH and FSH in rhesus monkeys by the administration of a potent inhibitory analogue of LH-RH ( [N-Ac-D-Trp1, 3, D-p-Cl-Phe2, D-Phe6, D-Ala10]-LH-RH). (1983) (2)
- Position 4 substituted somatostatin analogs: increased binding to somatostatin receptors in pituitary and brain. (1983) (2)
- Unaltered plasma GH levels in acromegalics and normal men and women after administration of (Pyro)Glu-Ser-Gly-NH2, a proposed GH-releasing hormone. (1974) (2)
- Selective Conversion of O-Succinimidyl Carbamates to N-(O-Carbamoyl)-succinmonoamides and Ureas. (2002) (2)
- Conformational scan of bombesin/GRP reveals new position 11 receptor antagonists (1994) (2)
- [35] Solid phase synthesis of luteinizing hormone-releasing hormone and its analogues (1975) (2)
- Comparison of methionine-enkephalin and morphine in the stimulation of gastric secretion (1978) (2)
- (N-Ac-Tyr1.d-Phe2)-θRF(1–29)-NH2 and (d-PHE2)-VIP act as vip antagonists and reduce neurally mediated lower esophageal sphincter (LES) relaxation in the CAT (1986) (2)
- Molecular basis of the selectivity of the gastrin-releasing peptide receptor (GRPR) for the neurotransmitter, GRP (2001) (2)
- Strategies in the design of synthetic agonists and antagonists of the VIP-glucagon-GRF series (1985) (2)
- Polyfluoroalkyl derivatives of nitrogen. Part XXXVII. Reaction of N-bromobistrifluoromethylamine with propene under ionic and free-radical conditions (1972) (2)
- Involvement of VPAC1 and VPAC2 receptors in increasing local pancreatic blood flow in anesthetized rats. (2008) (2)
- Effect of a somatostatin analogue on trophic hormone levels in acromegalic patients with elevated hGH after adenomectomy and treatment with bromocriptine. (2009) (2)
- Cholera toxin pretreatment of the human lymphoblastic cell line sup T1 affects the selectivity of helodermin/VIP receptors (1989) (2)
- Pituitary and Testicular Response to LH‐RH and to a Long‐Acting Analogue (D‐Leu‐6‐LH‐RH‐Ethylamide) (2009) (2)
- Pharmacology of GRF and Somatostatin: Positive and Negative Control of GH Release (1994) (2)
- Polyfluoroalkyl derivatives of nitrogen. Part XXXVIII. Reaction of N-bromobistrifluoromethylamine with allyl chloride; preparation of NN-bistrifluoromethylprop-2-enylamine (1973) (1)
- Conversion of O-Succinimidyl Carbamates to N-(O-Carbamoyl)-succinmonoamides and Ureas: Effects of N-Substituents and Reaction Conditions on the Reaction Pathway. (2002) (1)
- Method of modulating cell proliferation of medullary thyroid carcinoma. (2002) (1)
- STIMULATION OF GROWTH HORMONE AND PROLACTIN RELEASE BY MORPHINE AND OPIATE-LIKE PEPTIDES (1978) (1)
- Effects of a superactive analogue of LH-RH on the hypothalamo-pituitary-testicular axis in male rats pretreated with estrogens. (1981) (1)
- Receptors for mammalian bombesin/GRP and neuromedin B have greatly differing ligand binding requirements (1992) (1)
- Pharmacology and intracellular signaling of the human bombesin receptor subtype 3 (1998) (1)
- Inhibition of growth hormone and glucagon release by Phe-4-somatostatin in patients with acromegaly. (1984) (1)
- Inhibition of testosterone production and pituitary LH-RH binding in rats by LH-RH antagonists (1980) (1)
- GRF (1-29) analogs with high in vivo and in vitro potencies in the rat (1992) (1)
- Synthesis of D Phe2, Phe3, D Phe6 LH RH, a potent inhibitor of LH RH (1975) (1)
- Hypothalamic peptide hormones and their analogues (1978) (1)
- CYCLIC ANALOGS OF LUTEINIZING HORMONE-RELEASING HORMONE WITH SIGNIFICANT BIOLOGICAL ACTIVITIES (1979) (1)
- The actions of growth hormone release inhibiting hormone in man (1975) (1)
- Endogenous opiates: 1979(1). (1980) (1)
- Behavioral effects of D-Ala2-beta-endorphin in squirrel monkeys. (1978) (1)
- Clinical Studies With d-Trp6-Luteinizing Hormone-Releasing Hormone in Anovulatory Women**Supported by a grant from Patronato de Investigaciones Endocrino Metabólicas, Fundación General Mediterránea, Madrid, Spain. (1978) (1)
- Editorial: GPCR-Targeted Drug Development. (2016) (1)
- Novel Tandem Aldol Intramolecular Cyclization of Substituted N-Benzylpiperidine-4-one: Synthesis of Novel-Type Nitrogen 2,8-Phenanthroline Heterocycles (2015) (1)
- [Leu13-psi(CH2NH)Leu14]bombesin is a specific bombesin receptor antagonist in Swiss 3T3 cells. (1988) (1)
- Bombesin stimulates bicarbonate and fluid secretion in isolated guinea-pig pancreatic ducts via GRP-preferring bombesin receptors (1998) (1)
- Chemical structure and biological activity of hormones and related compounds (1981) (1)
- Identification of a simplified polyalaninated VIP analogue with high affinity for human VIP1 receptors (2000) (1)
- Pharmacology of Growth Hormone-Releasing Hormone and Its Peptide Analogs (2000) (1)
- Structure — Function of LH-RH Analogs and Design Applications to other Peptide Systems (1984) (1)
- Gastrin releasing peptide-preferring bombesin binding sites in human lung. (1994) (1)
- The utility of reductive alkylation in solid phase peptide synthesis (1988) (1)
- Corrigendum to “A multi-tyrosinated sst1/2 receptor preferring somatostatin agonist inhibits reflex and immune-mediated secretion in the guinea pig colon” [Regul. Pept. 114 (2003) 51–60] (2003) (1)
- Potent long-acting alkylated analogs of growth hormone-releasing factor. (1988) (1)
- 10 lH RH antagonists in females (1984) (1)
- Human Serum Albumin (HSA) and ItsApplications as a Drug Delivery Vehicle (2020) (1)
- Somatostatin receptor antagonists based on a mixed neuromedin B antagonist/somatostatin agonist (2002) (1)
- Activation of central somatostatin receptor (SSTR) 5 stimulates gastric emptying in rats (1998) (1)
- Effects of H-Phe-Ile-Tyr-His-Ser-Tyr-Lys-OH on the in vitro uptake and release of radiolabelled dopamine, noradrenaline and serotonin in rat brain hypothalamic slices (1984) (1)
- [Response to acute administration of pituitary inhibiting hormone, growth hormone and one of its analogues in acromegaly]. (1975) (1)
- EFFECT OF SIMPLE AMINO ACID REPLACEMENTS ON THE BIOLOGICAL ACTIVITY OF LUTEINIZING HORMONE-RELEASING HORMONE (1974) (1)
- 56 Cranial irradiation for cerebral tumors in childhood–evidence for a hypothalamic defect in growth hormone release (1985) (0)
- Intravitreal Injection of Novel Combretastatin Analog MV-5-40 (2003) (0)
- Tyr-MIF 1 (Tyr-Pro-Leu-Gly-NH2) Affects Passive Avoidance Behavior but not Motor Activity in Rats, (1983) (0)
- Analogs of glucagon-like peptide-1 (GLP-1) (1999) (0)
- POLYFLUORALKYL DERIVATIVES OF NITROGEN PART 38, REACTION OF N-BROMOBISTRIFLUOROMETHYLAMINE WITH ALLYLCHLORIDE, PREPARATION OF N,N-BISTRIFLUOROMETHYLPROP-2-ENYLAMINE (1973) (0)
- Native human bombesin receptor subtype 3 has a unique pharmacology (1998) (0)
- INITIAL BIODISTRIBUTION STUDIES OF A RADIOIODINATED GASTRIN RELEASING PEPTIDE (GRP) ANTAGONIST: A POTENTIAL ONCOLOGICAL DETECTION AGENT (1998) (0)
- Anti-luteinizing (LH)-releasing activity of several analogues of LH-releasing hormone. (1975) (0)
- Distribution of radioimmunoassayable PACAP: Abundance in the brain and testes (1992) (0)
- A synthetic bombesin-analogue acting as specific bombesin receptor antagonist (1988) (0)
- A method for preparing an octapeptide (1986) (0)
- Somatostatin-induced augmentation of the descending phase of the peristaltic reflex is mediated by the somatostatin receptor type 2 (SST2) (2000) (0)
- SYNTHESIS AND BIOLOGICAL ACTIVITY OF POSITION 1 ANALOGS OF LH-RH (1977) (0)
- Vasoactive intestinal peptide (VIP) structural requirements for high affinity interaction with the VIP receptor in pancreatic acini (1998) (0)
- Solid phase synthesis on luteinizing hormone-releasing hormone and its analogues. (1975) (0)
- SYNTHESIS AND BIOLOGICAL ACTIVITY OF LH-RH ANALOGS MODIFIED AT THE CARBOXYL TERMINUS (1975) (0)
- Synthesis and biological actions of prosomatostatin ( somatostatin / synthetic prohormone / insulin / glucagon / growth hormone ) (0)
- Somatostatin (SST) enhances cAMP-dependant shortcircuit current (Isc) in human colon via SST receptor subtype-2 (SSTR-2) (1998) (0)
- Mo1784 Identification of Selective Agonists for the Hpac1 Receptor (2014) (0)
- Abstracts of the Hans Selye Symposium on Neuroendocrinology and Stress (1989) (0)
- Method for the synthesis of a peptide containing a non-peptide bond. (1987) (0)
- Physiological studies on the LH- and FSH- releasing hormone its analogues, and antisera. (1974) (0)
- Therapeutically active peptides, particularly bombesinantagonistiske litorinantagonistiske and peptides as well as process for their preparation (1989) (0)
- Responses of serum GH and somatomedin-C to an analogue of GHRH in children with growth hormone deficiency (1984) (0)
- IMPROVED ANTAGONISTS OF LUTEINIZING HORMONE-RELEASING HORMONE MODIFIED IN POSITION 7 (1985) (0)
- 133 Bombesin Receptor Subtype-3 Signaling Targets Glut4 Translocation in Human Adipocytes (2009) (0)
- Behavioural Modulation by Systemic Administration of Enkephalins and Endorphins (1981) (0)
- [Synthetic hypothalamic gonadotropin-releasing hormone (LH-RH) and ovulation: a possibility of "programmed" ovulation to regulate fertility in women (author's transl)]. (1975) (0)
- The orphan receptor, BRS-3, causes tyrosine phosphorylation (TYR-P) of focal adhesion kinase (p125FAK) (1998) (0)
- Role for somatostatin receptors in discriminating between mechanosensitive release of 5-HT and PGE2 in the initiation of secretory reflexes in the guinea pig colon* (1998) (0)
- Letter: Analogues of growth-hormone release-inhibiting hormone. (1975) (0)
- [Synthetic hypothalamic gonadotropin-releasing hormone -- LH-RH -- and ovulation: a possibility of programmed ovulation to control fertility in women.)] (1975) (0)
- Selective inhibition of sleep related growth hormone release by Phe-4-somatostatin. (1984) (0)
- Reduced Peptide Bond Pseudopeptide Analogues of Secretin (2001) (0)
- Identification and exploitation of structural foci that influence conformational mobility in somatostatin agonists and antagonists (2002) (0)
- Isolation and structure of pro-methionine-enkephalin: Potential enkephalin precursor from porcine hypothalamus (endorphins/pro-hormones) (0)
- POLYFLUOROALKYL DERIVATIVES OF NITROGEN PART 40, REACTION OF TRIFLUORONITROSOMETHANE WITH NN-BISTRIFLUOROMETHYLAMINO-SUBSTITUTED ALLENES (1973) (0)
- Foerfarande Foer framstaellning of nya tillvaexthormon frigoerande-like peptides. (1984) (0)
- Synthesis of camptothecin–amino acid carbamate linkers (2011) (0)
- Stimulation of Prolactin and Growth Hormone Release by Intraventricular Injection of Met-Enkephalin, β-Endorphin and Endorphin Analogues in the Rat (1978) (0)
- Isolation , structure , biological characterization , and synthesis of f 3-[ Tyr 9 ] melanotropin-( 9-18 ) decapeptide from pig hypothalami ( aand P-melanottopin / {-lipotropin / corticotropin precursor ) (0)
- FACILE SOLID-PHASE PREPARATION OF PEPTIDES CONTAINING THE CH2NH PEPTIDE BOND ISOSTERE AND APPLICATION TO THE SYNTHESIS OF SOMATOSTATIN (SRIF) OCTAPEPTIDE ANALOGUES (1987) (0)
- Cyclic Bombesin/GRP Analogs Which Retain Either Agonist or Antagonist Activity, (1992) (0)
- New potent somatostatin receptor 2 antagonist inhibits srif and srif-mediated effects on pentagastrin-stimulated gastric acid secretion in conscious rats (1998) (0)
- 114 Immune responsiveness in rats following hypophysectomy (1988) (0)
- W1581 The Pharmacophore for Human Bombesin Receptors(BnR) Differs Significantly from That of Rat (2009) (0)
- Alternative bridging groups for proline in endothelin pentapeptide receptor antagonists (1994) (0)
- Development of a novel high affinity bombesin (BN)-camptothecin analog and demonstration of its ability to effect receptor-related cytotoxicity in normal and tumor cells (2003) (0)
- PROC.V INT.CONGR.ENDOCRINOLOGY. VOL.I (1977) (0)
- Present status of LH-RH analog chemistry (1985) (0)
- The non-therapeutic method of promoting the release of growth hormone in an animal (2005) (0)
- S1821 The Attenuating Action of Vasoactive Intestinal Peptide (VIP) on Pancreatic Inflammation is Mediated by Ameliorating Both Oxidative Stress Effects and Cytokine Production (2010) (0)
- Isolation and characterization of novel hypothalamic polypeptides homologous with VIP (1989) (0)
- Therapeutic efficacy of LHRH analoger. (1985) (0)
- D-Ala2,F5Phe4-dynorphin amide, an opiate with analgesic and toxic properties. (1992) (0)
- DB110690 197..207 (2011) (0)
- PHYSIOLOGICAL, VETERINARY, AND CLINICAL EFFECTS OF HYPOTHALAMIC RELEASING HORMONES (RH), ESPECIALLY LH‐RH (1974) (0)
- Oktapeptidanaloge of somatostatin with threonine at position 6 (1990) (0)
- Effect of cycloheximide on the LH release induced by a superactive analog of LH-RH. (1980) (0)
- Blockade of GRP receptors inhibits gastric acid secretion independent of plasma gastrin release in humans (2000) (0)
- Somatostatin analogs selective for sub-type 2 and 5 of the somatostatin receptor suppress with different patterns growth hormone (GH) secretion in human GH-secreting adenomas cultured in vitro (1998) (0)
- W1758 Selectivity and Potency of Putative Neuromedin B Receptor (Nmbr) Antagonists for Human Bombesin Receptors (Bnr) (2008) (0)
- S1707 Assessment of a New, Novel, Putative High Affinity and Selective Ligand for the Hbrs3 Receptor and Comparison to Older Less Selective Ligands (2010) (0)
- Rational design of peptide agonists selective for the bombesin receptor subtype 3 (2000) (0)
- Therapeutically effective peptides (1991) (0)
- POLYFLUOROALKYL DERIVATIVES OF NITROGEN PART 39, PREPARATION OF N,N-BISTRIFLUOROMETHYLAMINO-SUBSTITUTED ALLENES (1973) (0)
- Peptides as drug (1989) (0)
- Effects of secretin, VIP, CRF, and other neuro-gastrointestinal peptides on rat insulin and glucagon levels (1983) (0)
- Comparative efficacy of synthetic glucagon analogs on rat liver and heart adenylate cyclase (1985) (0)
- VPAC1 receptors as molecular targets in breast cancer (2006) (0)
- STRUCTURE-ACTIVITY STUDIES ON THE N-TERMINAL REGION OF GROWTH HORMONE RELEASING FACTOR (1985) (0)
- Treatment of cancer with somatostatin analogue with it. (1988) (0)
- SYNTHESIS AND BIOLOGICAL PROPERTIES OF THE 2-L-β-(PYRAZOLYL-1)ALANINE ANALOGS OF LUTEINIZING HORMONE-RELEASING HORMONE AND THYROTROPIN-RELEASING HORMONE (1976) (0)
- LHRH antagonists and contraception. (1985) (0)
- Correlation between leuteinizing hormone responses to luteinizing hormone-releasing hormone (LH-RH) and to D-leu-6-LH-RH-ethylamide in patients with hypothalamo-pituitary disease. (1976) (0)
- Contents, Vol. 45, 1987 (1987) (0)
- First neuromedin B receptor antagonists are based on somatostatin octapeptide analogues (1994) (0)
- STRUCTURE-DEPENDENT INHIBITORY EFFECT OF GALANIN ON INSULIN, GASTRIC ACID AND PANCREATIC AMYLASE SECRETION IN RAT (1993) (0)
- A process for the preparation of peptides having growth hormone releasing activity (1994) (0)
- Discovery of a selective agonist for the novel bombesin (BN) receptor subtype 3 (2000) (0)
- Modulation of secretin release by neuropeptides in secretin-producing cells. (1998) (0)
- Endogenous Opiate Systems May Modulate Learning and Memory (1984) (0)
- Study of Antiangiogenic Somatostatin Conjugate (JF–10–81) (2004) (0)
- Toxicity of a possible therapeutic GRF analogue in vivo in monkeys but in rats is likely due to VIP receptor agonist activity (2000) (0)
- Structural determinants of high affinity VIP2-R (VPAC2) interaction and identification of a simplified high affinity agonist (2001) (0)
- The effect of beta-(Tyr9)melanotropin-(9-18) on the active avoidance and open-field behavior on rats pretreated with atropine or propranolol. (1984) (0)
- Differentiation of somatostatin receptors involved in inhibition of gastric acid and growth hormone secretion with halogenated Trp8 analogues [proceedings]. (1978) (0)
- Use of octapeptides for the treatment of receptor associated diseases neuromedin b. (1993) (0)
- Levels of Luteinizing Hormone (LH), Follicle-Stimulating Hormone, and 17β-Estradiol in Response to D-Trp6-LH-Releasing Hormone During Different Phases of the Menstrual Cycle in Normal Women**Supported by a grant from Patronato de Investigaciones Endocrino Metabolicas, Fundacion General Mediterranea, (1978) (0)
- United States Patent ( 19 ) Coy et al . 54 BRADYKININ ANALOGS WITH NON-PEPTDE BOND 75 Inventors : (2017) (0)
- Galanin inhibits sodium oleate-stimulated CCK release from STC-1 cells* (1998) (0)
- ANALOGS OF LUTEINIZING HORMONE-RELEASING HORMONE CONTAINING DERIVATIVES OF PHENYLALANINE IN PLACE OF TYROSINE (1973) (0)
- The effect of analogues of hypothalamic hormones on the growth of the Swarm chondrosarcoma (1982) (0)
- [Biological studies with enkephalins and endorphins and their analogs]. (1978) (0)
- SYNTHESIS AND BIOLOGICAL PROPERTIES OF (2-L-BETA-(PYRAZOLYL-3)ALANINE)-LUTEINIZING HORMONE-RELEASING HORMONE (1974) (0)
- Peptide-Neuromedin B (NMB) Receptor Interactions: Comparison with Gastrin-Releasing Peptide (GRP) Receptor Interactions (1993) (0)
- Elucidation of receptor domains of gastrin-releasing peptide receptor (GRPR) determining high selectivity for peptide antagonists (1998) (0)
- Agonists and antagonists of urotensin-ii. (2001) (0)
- Tissue distribution of PACAP receptor subtypes in rat (1992) (0)
- Inhibition by LHRH antagonist of steroid secretion from luteal and leydig cells in vitro (1984) (0)
- The method of therapeutically useful, and for the preparation of modified bombesin litoriinipeptidianalogien (1989) (0)
- Pituitary Adenylate Cyclase Activating Peptide Receptors Regulate the Growth of Non-Small Cell Lung Cancer Cells 1 (2006) (0)
- Effect of the carboxyl terminus of the human VIP2 receptor (VPAC2) on receptor affinity, adenylate cyclase activation and receptor internalization (2001) (0)
- Subject Index Vol. 45, 1987 (2004) (0)
- Erratum to ‘Gastrin releasing peptide-preferring bombesin binding sites in human lung’ [Eur. J. Pharmacol. 265 (1994) 117–120] (1995) (0)
- Plasma gonadotropin response to D-Ala6-LH-RH propylamide. (1978) (0)
- Somatostatin Analogs therapeutic. (1987) (0)
- POLYFLUOROALKYL COMPOUNDS OF SILICON PART 10, FURTHER SILANES CONTAINING THE BIS(TRIFLUOROMETHYL)AMINO‐GROUP (1974) (0)
- Selective Somatostatin Receptor Type 2 Antagonism Prevents Hypoglycaemia In Type 1 Diabetic BB Rats (2012) (0)
- Influence of methionine-enkephalin and morphine on the myoelectrical activity of the small bowel (1978) (0)
- Evaluation of Intravitreal Toxicity of Somatostatin Conjugate (JF-10-81), an Antiangiogenic Compound (2003) (0)
- Somatostatin : A potent , selective inhibitor of growth hormone release ( peptides / pituitary / bioassay / receptors / somatotropin ) (2003) (0)
- Comparative structural requirements of GRF analogs for occupancy and coupling to adenylate cyclase of GRF- and VIP receptors (1985) (0)
- Thyrotrophin and prolactin response to beta-(pyrazolyl-1)-alanine-2-TRH in normal males. (1981) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David H. Coy?
David H. Coy is affiliated with the following schools: